文献速递真菌感染

条形码磁珠多重PCR检测BALF真菌病原体的评估

Evaluation of a multiplex PCR assay using barcoded magnetic bead technology for detection of fungal pathogens in bronchoalveolar lavage fluid.
PubMed 文献 · Clin Microbiol Infect · 2025-05-27

本研究前瞻性纳入323例疑似肺部侵袭性真菌感染(IFI)患者,评估Applied BioCode(ABC)条形码磁珠多重PCR assay单独及联合其他方法诊断IFI的性能。ABC assay单独敏感性43.2%、特异性98.5%;与BAL GM(≥0.5)联合5小时内可检出70.4%的证实/临床诊断IFI;ABC assay联合真菌培养和BAL GM可将敏感性提高至88.6%,特异性93.5%。

要点

  • ABC assay单独检测BALF真菌的敏感性为43.2%(95% CI: 28-59%),特异性为98.5%(95% CI: 96-99%)。
  • ABC assay联合BAL GM(≥0.5)可在5小时内检出70.4%(95% CI: 54-83%)的证实/临床诊断IFI。
  • ABC assay联合真菌培养和BAL GM(任一阳性即判定)敏感性88.6%(95% CI: 75-96%),特异性93.5%(95% CI: 90-96%)。

核心结论

  • ABC assay与BAL GM及真菌培养联合可显著提高IFI的诊断准确性,但仍需进一步验证以优化其临床使用。

研究设计与样本

  • 前瞻性研究,2023年8月至2024年3月纳入323例疑似肺部IFI患者(44例证实/临床诊断IFI,279例非IFI)。

主要发现

  • ABC assay单独敏感性43.2%(95% CI: 28-59%),特异性98.5%(95% CI: 96-99%)。
  • ABC assay联合BAL GM(≥0.5)5小时内检出70.4%(95% CI: 54-83%)的证实/临床诊断IFI。
  • ABC assay联合真菌培养和BAL GM(任一阳性即判定)敏感性88.6%(95% CI: 75-96%),特异性93.5%(95% CI: 90-96%)。
  • ABC assay敏感性不受抗真菌治疗影响:治疗中46.1%(95% CI: 19-74%)vs 未治疗42.0%(95% CI: 24-60%),p 0.77。
  • 真菌培养敏感性受抗真菌治疗影响:治疗中23.0%(95% CI: 0-53%)vs 未治疗64.0%(95% CI: 45%-80%),p = 0.01。

关键数值与推荐

  • ABC assay可同时检测BALF中22种真菌病原体,5小时内出结果。
  • BAL GM阳性阈值定义为≥0.5。
  • 联合策略中IFI判定标准为联合检测中任一方法阳性。

临床怎么用

  • 对于疑似肺部IFI患者,可考虑将ABC assay与BAL GM(≥0.5)联合使用以在5小时内提高检出率。
  • ABC assay联合真菌培养和BAL GM可提高敏感性至88.6%,但特异性降至93.5%。
  • ABC assay在抗真菌治疗期间仍保持敏感性,而真菌培养敏感性下降。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Invasive fungal infections (IFIs) are increasingly prevalent, particularly in immunocompromised patients. Traditional culture-based diagnostic methods have limitations, including low sensitivity and long turnaround times. The Applied BioCode (ABC) assay, utilizing barcoded magnetic bead technology, enables simultaneous detection of 22 fungal pathogens directly in bronchoalveolar lavage (BAL) fluids in 5 hours. This study aimed to assess the ABC's diagnostic performance in combination with other methods for diagnosis of IFIs. METHODS: A prospective study was conducted from August 2023 to March 2024 in patients with suspected pulmonary IFIs. BAL samples were tested simultaneously using the ABC assay, fungal microscopy, culture, BAL galactomannan (GM), and an in-house Pneumocystis jirovecii PCR. The diagnostic performance of the ABC assay was evaluated individually and in combination with other methods. RESULTS: Among 323 patients (44 proven/probable IFIs, 279 non-IFIs), the ABC assay demonstrated a sensitivity of 43.2% (95% CI: 28-59%) and a specificity of 98.5% (95% CI: 96-99%). When combined with BAL GM (≥0.5), the ABC assay was able to detect 70.4% (95% CI: 54-83%) of cases with proven/probable IFIs in 5 hours. When the ABC assay, fungal culture, and BAL GM (≥0.5) were combined and IFIs were considered to be detected if either of the combined tests was positive, sensitivity increased to 88.6% (95% CI: 75-96%), with a specificity of 93.5% (95% CI: 90-96%). The ABC assay' sensitivity was not affected by antifungal therapy (46.1% [95% CI: 19-74%] with antifungal therapy vs. 42.0% [95% CI: 24-60%] without antifungal therapy, p 0.77), unlike fungal culture (23.0% [95% CI: 0-53%] with antifungal therapy vs. 64.0% [95% CI: 45%-80%] without antifungal therapy, p = 0.01). DISCUSSION: The ABC assay, when combined with BAL GM and fungal culture, significantly improved diagnostic accuracy for IFIs. Further validation of the ABC assay is warranted to optimize its clinical use.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Permpalung N, Uhteg K, Rodrigues M, et al. Evaluation of a multiplex PCR assay using barcoded magnetic bead technology for detection of fungal pathogens in bronchoalveolar lavage fluid. Clin Microbiol Infect. 2025. PMID: 40441351. doi:10.1016/j.cmi.2025.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。